ÂÜÀòÂÒÂ×

Dave Lonergan has held various senior positions in the pharmaceutical industry. Dave started their career at Tranzyme Pharma as a Group Leader in Chemistry before moving on to Nanosyn, where they served as the Director of Medicinal Chemistry and San Diego Operations. Lonergan then worked at Research Corporation Technologies as a Venture Capital Associate and Project Manager. Dave later joined Nanosyn again as the Director of Project and Alliance Management. Lonergan then served as the Senior Director of Business Development at eMolecules before becoming the Senior Director of Chemistry at PharmAkea Therapeutics. Dave is currently the Director of Business Development at Enamine Ltd.

Dave Lonergan has a strong educational background in the field of Chemistry. Dave completed their Bachelor of Science (Honours) degree in Biology-Chemistry from the University of New Brunswick, starting in 1990 and completing it in 1994. Dave then pursued further studies at the same institution and obtained a PhD in Chemistry from 1994 to 1997. After completing their PhD, Dave Lonergan continued their education and gained practical experience by undertaking an Industrial Post-Doctoral program in Chemistry at the Université de Sherbrooke. The specific start and end years for this program were not provided.